BrainsWay Ltd. (BWAY) has a MoatMap StockRank of 84/100 based on Quality (68/100), Value (13/100), and Momentum (83/100) factor scores. The current signal is STRONG BUY. BrainsWay Ltd., a healthcare company based in Israel, faces two immediate disqualifiers. Firstly, its extremely low Value score (V: 13) indicates it is highly expensive, failing the 'Growth at a Reasonable Price' and 'Margin of Safety' criteria. Secondly, its geographic location in Israel exposes it to significant, unquantifiable geopolitical risks, making it a casualty of regional instability and contradicting the asymmetric risk-reward principle.